Active Biotech AB Interim Report January - June 2013

        Print
| Source: Active Biotech AB
Events during January - June 2013:

Laquinimod
· positive results from Phase IIa study of laquinimod in active lupus nephritis
· Teva plans continued clinical development of laquinimod for the treatment of
lupus nephritis
· data presented at AAN showed a slower disability progression for multiple
sclerosis patients who commenced early treatment with laquinimod compared with
delayed treatment

Tasquinimod
· analysis plan for Phase III trial updated; primary PFS analysis expected at
the same time as first interim overall survival analysis in 2014
· Phase II follow-up study shows an impact of tasquinimod on bone metastases as
measured by
Bone Scan Index (BSI); results presented at ASCO

ANYARA
· improved overall survival in a subgroup of renal cell cancer patients in the
Phase II/III study; results presented at ASCO

57-57 (paquinimod)
· clinical trial in systemic sclerosis concluded, evaluation under way

ISI
· patent applications filed

                                                       Jan - Jun      Jan - Dec

  (MSEK)                                      2013            2012       2012
-------------------------------------------------------------------------------
   *      Net sales                                 5.0          96.6   227.9

   *      Operating loss                      -156.5          -120.6   -163.2

   *      Net loss                            -159.2          -123.5   -175.0

   *      Earnings per share (SEK)              -2.18           -1.79    -2.54

   *      Cash and cash equivalents
     (MSEK)
                                                389.1           383.7    216.7


  For further information, please contact:

  Tomas Leanderson, President and CEO
  Tel: +46 (0)46-19 20 95

  Hans Kolam, CFO
  Tel: +46 (0)46-19 20 44

  Active Biotech AB (Corp. Reg. No. 556223-9227)
  Box 724, SE- 220 07 Lund
  Tel: +46 (0)46-19 20 00
  Fax: +46 (0)46-19 11 00

  This report is also available at www.activebiotech.com


[HUG#1721488]